ID   HTYC_ASPRU              Reviewed;         366 AA.
AC   K0E689;
DT   25-APR-2018, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2012, sequence version 1.
DT   07-APR-2021, entry version 29.
DE   RecName: Full=Isopropyl malate dehydrogenase htyC {ECO:0000303|PubMed:22998630};
DE            EC=1.1.1.85 {ECO:0000305|PubMed:22998630};
DE   AltName: Full=L-homotyrosine biosynthetic cluster protein C {ECO:0000303|PubMed:22998630};
GN   Name=htyC {ECO:0000303|PubMed:22998630};
OS   Aspergillus rugulosus (Emericella rugulosa).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC   Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus.
OX   NCBI_TaxID=41736;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, PATHWAY, AND BIOTECHNOLOGY.
RC   STRAIN=ATCC 58397 / NRRL 11440;
RX   PubMed=22998630; DOI=10.1021/ja307220z;
RA   Cacho R.A., Jiang W., Chooi Y.H., Walsh C.T., Tang Y.;
RT   "Identification and characterization of the echinocandin B biosynthetic
RT   gene cluster from Emericella rugulosa NRRL 11440.";
RL   J. Am. Chem. Soc. 134:16781-16790(2012).
CC   -!- FUNCTION: Isopropyl malate dehydrogenase; part of the gene cluster that
CC       mediates the de novo generation of L-homotyrosine from acetyl-CoA and
CC       4-hydroxyphenyl-pyruvate (PubMed:22998630). L-homotyrosine is a
CC       building block of echinocandin B, a fungal lipidated cyclic hexapeptide
CC       that acts as an antifungal agent (PubMed:22998630). L-homotyrosine 4-
CC       hydroxyphenyl-pyruvate first undergoes an aldol-type condensation by
CC       htyA with the C-2 of acetyl-CoA followed by the release of CoA to form
CC       2-(4-hydroxybenzyl)-malate (PubMed:22998630). This is followed by
CC       isomerization of 2-(4-hydroxy-benzyl)-malate to 3-(4-hydroxybenzyl)-
CC       malate by htyD (PubMed:22998630). Thereafter, 3-(4-hydroxybenzyl)-
CC       malate undergoes decarboxylation and oxidation to form 2-oxo-4-(4-
CC       hydroxybenzyl)butanoic acid, coupled to reduction of NAD(+) to NADH by
CC       htyC (PubMed:22998630). The product then undergoes transamination
CC       catalyzed by htyB to form L-homotyrosine (PubMed:22998630).
CC       {ECO:0000269|PubMed:22998630}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2R,3S)-3-isopropylmalate + NAD(+) = 4-methyl-2-oxopentanoate
CC         + CO2 + NADH; Xref=Rhea:RHEA:32271, ChEBI:CHEBI:16526,
CC         ChEBI:CHEBI:17865, ChEBI:CHEBI:35121, ChEBI:CHEBI:57540,
CC         ChEBI:CHEBI:57945; EC=1.1.1.85;
CC         Evidence={ECO:0000255|RuleBase:RU004445};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000255|RuleBase:RU004445};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|RuleBase:RU004445};
CC       Note=Binds 1 Mg(2+) or Mn(2+) ion per subunit.
CC       {ECO:0000255|RuleBase:RU004445};
CC   -!- PATHWAY: Antifungal biosynthesis. {ECO:0000305|PubMed:22998630}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000255|RuleBase:RU004445}.
CC   -!- BIOTECHNOLOGY: Due to their effectiveness as antifungal agents,
CC       echinocandin derivatives can be used for the treatment of human
CC       invasive candidiasis (PubMed:22998630). {ECO:0000269|PubMed:22998630}.
CC   -!- SIMILARITY: Belongs to the isocitrate and isopropylmalate
CC       dehydrogenases family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; JX421685; AFT91394.1; -; Genomic_DNA.
DR   SMR; K0E689; -.
DR   BioCyc; MetaCyc:MONOMER-19236; -.
DR   GO; GO:0003862; F:3-isopropylmalate dehydrogenase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:InterPro.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0009082; P:branched-chain amino acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009098; P:leucine biosynthetic process; IEA:UniProtKB-KW.
DR   InterPro; IPR019818; IsoCit/isopropylmalate_DH_CS.
DR   InterPro; IPR024084; IsoPropMal-DH-like_dom.
DR   InterPro; IPR004429; Isopropylmalate_DH.
DR   PANTHER; PTHR42979; PTHR42979; 1.
DR   Pfam; PF00180; Iso_dh; 1.
DR   SMART; SM01329; Iso_dh; 1.
DR   TIGRFAMs; TIGR00169; leuB; 1.
DR   PROSITE; PS00470; IDH_IMDH; 1.
PE   1: Evidence at protein level;
KW   Amino-acid biosynthesis; Branched-chain amino acid biosynthesis;
KW   Leucine biosynthesis; Magnesium; Manganese; Metal-binding; NAD; NADP;
KW   Oxidoreductase.
FT   CHAIN           1..366
FT                   /note="Isopropyl malate dehydrogenase htyC"
FT                   /id="PRO_0000443853"
FT   NP_BIND         71..73
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:O75874"
FT   NP_BIND         277..282
FT                   /note="NADP"
FT                   /evidence="ECO:0000250|UniProtKB:O75874"
FT   METAL           221
FT                   /note="Magnesium or manganese"
FT                   /evidence="ECO:0000250|UniProtKB:P50213"
FT   METAL           246
FT                   /note="Magnesium or manganese"
FT                   /evidence="ECO:0000250|UniProtKB:P50213"
FT   METAL           250
FT                   /note="Magnesium or manganese"
FT                   /evidence="ECO:0000250|UniProtKB:P50213"
FT   BINDING         91
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:O75874"
FT   BINDING         130
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:P50213"
FT   SITE            137
FT                   /note="Critical for catalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P50213"
FT   SITE            187
FT                   /note="Critical for catalysis"
FT                   /evidence="ECO:0000250|UniProtKB:P50213"
SQ   SEQUENCE   366 AA;  38706 MW;  E1F25BB2C882E8A6 CRC64;
     MVKTFDIVVF PGDYGGPEVL GEIQSQYEQE VTFNLKYHLL GGASFDAHGT PIADEALTDA
     KAASAVLLGA VGGPAWDKAP IPVESGLGRL RKALDAFGNL RPVKFIHPIL TETSALKEQV
     CRGADLLIIR ELTGGIYYGA RQEHDGTLNA ASDLDHYERA QVQRVARLAG TLAMSTQPPT
     PITSLDKANL LAACGRLWRG VVEETIRREF PDVELKHMLI DTAAMTLGCR PTKLNGIVLT
     SNMFGDIISD QASAIPGSLG LLPSASLCAI PGGESGGCVH GIYEPVHGSA PDIAGQGIIN
     PTGMILSVAM MLRYSLDMPA AATAVETAVS RVIERGGRTR DVGGTTSTAE FGDQVVACLR
     ENTEDK
//
